The Piramal Enterprises board on Thursday approved a proposal to demerge the pharmaceutical business, which would result in two separate listed entities exclusively in the pharma and finance business. Shareholders of Piramal Enterprises will get four shares of Piramal Pharmaceuticals for every one share they hold. Two operating subsidiaries of PPL will also be amalgamated with their parent.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3oFlkxO
https://ift.tt/3uRpEuV
0 Comments